STAT+: Pharma’s free lunches for doctors boost inappropriate prescribing, analysis finds
The gifts and payments that doctors receive from drugmakers increased inappropriate prescribing, likely leading to rising health care costs, according to a new review.
A review of numerous studies analyzing the impact of pharmaceutical companies on medical practice has revealed that gifts, payments and promotional efforts from drug manufacturers have been linked to inappropriate prescribing. The analysis, conducted by Cochrane, suggests that these incentives may have contributed to an increase in prescriptions written, potentially driving up healthcare costs.
Moreover, pharmaceutical advertising and educational initiatives directed at doctors may also have exacerbated the issue of inappropriate prescribing. The review indicates that these promotional tactics likely led to higher prescription rates and increased prescription costs. However, conflict-of-interest policies that limit or monitor interactions between pharmaceutical companies and healthcare professionals appear to have positively influenced prescribing practices.
The analysis, however, was not conclusive about the effects of free drug samples and other promotional materials on decisions regarding the inclusion of specific drugs in hospital formularies – a list of medications approved for use and commonly stocked in hospitals or health systems. Despite the findings, it is important to note that the evidence was insufficient to establish a definitive conclusion on this matter.
Written by urgent.news from STAT News's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
